Advancing Clinical Innovation with OXON at 19CTSS
May 21-22, 2025 | Munich
OXON will support the summit showcasing expanded services and new developments in RWE.
We are proud to participate as a Silver Sponsor and exhibitor at the 19th Clinical Trials Strategic Summit (CTSS), taking place in Munich on May 21–22, 2025.
This year’s Clinical Trial Summit brings together leaders across the life sciences sector to explore innovation in clinical development, the integration of real-world data (RWD), and decentralized research strategies—creating a valuable forum for collaboration and idea exchange.
As a full-service CRO, OXON continues to support pharmaceutical and biotech partners with full-service, methodologically rigorous solutions across the clinical lifecycle, from early-phase clinical trials to post-marketing studies.
At Booth #7, we’ll showcase how our Clinical Trials and Real-World Evidence (RWE) services work in synergy to strengthen clinical development strategies—bridging scientific excellence, regulatory expectations, and operational efficiency.
Our key capabilities include:
-
Integrated Phase I–IV solutions, leveraging real-world data from protocol design through post-authorization.
-
Use of the FDA/EMA-validated Pocock Win Ratio methodology to improve statistical power, particularly in rare diseases and early-phase research.
-
Deep expertise in hybrid and observational study design across multiple therapeutic areas, including oncology, neuroscience, CVRM, immunology, and orphan indications.
-
A flexible, global operational model with footprints in Europe and the U.S., enabling tailored collaboration across markets.
We look forward to connecting in Munich to explore how our expertise can help advance your clinical programs, from feasibility to market access.